TY  - GEN
AU  - Graves,Shawna F
AU  - Kouriba,Bourema
AU  - Diarra,Issa
AU  - Daou,Modibo
AU  - Niangaly,Amadou
AU  - Coulibaly,Drissa
AU  - Keita,Yamoussa
AU  - Laurens,Matthew B
AU  - Berry,Andrea A
AU  - Vekemans,Johan
AU  - Ripley Ballou,W
AU  - Lanar,David E
AU  - Dutta,Sheetij
AU  - Gray Heppner,D
AU  - Soisson,Lorraine
AU  - Diggs,Carter L
AU  - Thera,Mahamadou A
AU  - Doumbo,Ogobara K
AU  - Plowe,Christopher V
AU  - Sztein,Marcelo B
AU  - Lyke,Kirsten E
TI  - Strain-specific Plasmodium falciparum multifunctional CD4(+) T cell cytokine expression in Malian children immunized with the FMP2.1/AS02A vaccine candidate
SN  - 1873-2518
PY  - 2017///1010
KW  - Adjuvants, Immunologic
KW  - administration & dosage
KW  - Antibodies, Protozoan
KW  - blood
KW  - Antigens, Protozoan
KW  - immunology
KW  - CD4-Positive T-Lymphocytes
KW  - Child
KW  - Child, Preschool
KW  - Cytokines
KW  - Humans
KW  - Immunization, Secondary
KW  - Infant
KW  - Interferon-gamma
KW  - Interleukin-17
KW  - Interleukin-2
KW  - Malaria Vaccines
KW  - therapeutic use
KW  - Malaria, Falciparum
KW  - prevention & control
KW  - Mali
KW  - Membrane Proteins
KW  - Plasmodium falciparum
KW  - Protozoan Proteins
KW  - Tumor Necrosis Factor-alpha
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.vaccine.2016.04.019
ER  -